Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

JOURNAL ARTICLE published May 2020 in The Lancet

Research funded by National Health and Medical Research Council (APP1102604)

Authors: Matthew D Galsky | José Ángel Arranz Arija | Aristotelis Bamias | Ian D Davis | Maria De Santis | Eiji Kikuchi | Xavier Garcia-del-Muro | Ugo De Giorgi | Marina Mencinger | Kouji Izumi | Stefano Panni | Mahmut Gumus | Mustafa Özgüroğlu | Arash Rezazadeh Kalebasty | Se Hoon Park | Boris Alekseev | Fabio A Schutz | Jian-Ri Li | Dingwei Ye | Nicholas J Vogelzang | Sandrine Bernhard | Darren Tayama | Sanjeev Mariathasan | Almut Mecke | AnnChristine Thåström | Enrique Grande